Lyciumin A
| Internal ID | 0e67ef98-a519-4225-b5d6-31914baa4786 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Cyclic peptides |
| IUPAC Name | 11-(hydroxymethyl)-2-[[3-(4-hydroxyphenyl)-2-[[1-(5-oxopyrrolidine-2-carbonyl)pyrrolidine-2-carbonyl]amino]propanoyl]amino]-3,6,9,12-tetraoxo-5-propan-2-yl-1,4,7,10,13-pentazatricyclo[14.6.1.017,22]tricosa-16(23),17,19,21-tetraene-14-carboxylic acid |
| SMILES (Canonical) | CC(C)C1C(=O)NCC(=O)NC(C(=O)NC(CC2=CN(C(C(=O)N1)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C4CCCN4C(=O)C5CCC(=O)N5)C6=CC=CC=C26)C(=O)O)CO |
| SMILES (Isomeric) | CC(C)C1C(=O)NCC(=O)NC(C(=O)NC(CC2=CN(C(C(=O)N1)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C4CCCN4C(=O)C5CCC(=O)N5)C6=CC=CC=C26)C(=O)O)CO |
| InChI | InChI=1S/C42H51N9O12/c1-21(2)34-39(59)43-18-33(55)45-29(20-52)37(57)47-28(42(62)63)17-23-19-51(30-7-4-3-6-25(23)30)35(40(60)48-34)49-36(56)27(16-22-9-11-24(53)12-10-22)46-38(58)31-8-5-15-50(31)41(61)26-13-14-32(54)44-26/h3-4,6-7,9-12,19,21,26-29,31,34-35,52-53H,5,8,13-18,20H2,1-2H3,(H,43,59)(H,44,54)(H,45,55)(H,46,58)(H,47,57)(H,48,60)(H,49,56)(H,62,63) |
| InChI Key | IPOLXDNCMOVXCP-UHFFFAOYSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C42H51N9O12 |
| Molecular Weight | 873.90 g/mol |
| Exact Mass | 873.36571810 g/mol |
| Topological Polar Surface Area (TPSA) | 307.00 Ų |
| XlogP | 0.30 |
| Atomic LogP (AlogP) | -2.18 |
| H-Bond Acceptor | 12 |
| H-Bond Donor | 10 |
| Rotatable Bonds | 10 |
| 125708-06-7 |
| 11-(hydroxymethyl)-2-[[3-(4-hydroxyphenyl)-2-[[1-(5-oxopyrrolidine-2-carbonyl)pyrrolidine-2-carbonyl]amino]propanoyl]amino]-3,6,9,12-tetraoxo-5-propan-2-yl-1,4,7,10,13-pentazatricyclo[14.6.1.017,22]tricosa-16(23),17,19,21-tetraene-14-carboxylic acid |
| LyciuminA |
| CHEBI:172844 |
| AKOS040756589 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9210 | 92.10% |
| Caco-2 | - | 0.8766 | 87.66% |
| Blood Brain Barrier | - | 0.8750 | 87.50% |
| Human oral bioavailability | - | 0.5429 | 54.29% |
| Subcellular localzation | Mitochondria | 0.4502 | 45.02% |
| OATP2B1 inhibitior | - | 0.5758 | 57.58% |
| OATP1B1 inhibitior | + | 0.8244 | 82.44% |
| OATP1B3 inhibitior | + | 0.9294 | 92.94% |
| MATE1 inhibitior | - | 0.8238 | 82.38% |
| OCT2 inhibitior | - | 0.8250 | 82.50% |
| BSEP inhibitior | + | 0.8742 | 87.42% |
| P-glycoprotein inhibitior | + | 0.7435 | 74.35% |
| P-glycoprotein substrate | + | 0.8808 | 88.08% |
| CYP3A4 substrate | + | 0.7450 | 74.50% |
| CYP2C9 substrate | + | 0.6070 | 60.70% |
| CYP2D6 substrate | - | 0.8478 | 84.78% |
| CYP3A4 inhibition | - | 0.8976 | 89.76% |
| CYP2C9 inhibition | - | 0.8500 | 85.00% |
| CYP2C19 inhibition | - | 0.7835 | 78.35% |
| CYP2D6 inhibition | - | 0.9021 | 90.21% |
| CYP1A2 inhibition | - | 0.9112 | 91.12% |
| CYP2C8 inhibition | + | 0.7446 | 74.46% |
| CYP inhibitory promiscuity | - | 0.6290 | 62.90% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.8700 | 87.00% |
| Carcinogenicity (trinary) | Non-required | 0.6357 | 63.57% |
| Eye corrosion | - | 0.9904 | 99.04% |
| Eye irritation | - | 0.9077 | 90.77% |
| Skin irritation | - | 0.7885 | 78.85% |
| Skin corrosion | - | 0.9423 | 94.23% |
| Ames mutagenesis | - | 0.6800 | 68.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.4297 | 42.97% |
| Micronuclear | + | 0.9300 | 93.00% |
| Hepatotoxicity | - | 0.5397 | 53.97% |
| skin sensitisation | - | 0.8900 | 89.00% |
| Respiratory toxicity | + | 0.8111 | 81.11% |
| Reproductive toxicity | + | 0.9667 | 96.67% |
| Mitochondrial toxicity | + | 0.9625 | 96.25% |
| Nephrotoxicity | - | 0.7775 | 77.75% |
| Acute Oral Toxicity (c) | III | 0.6214 | 62.14% |
| Estrogen receptor binding | + | 0.8159 | 81.59% |
| Androgen receptor binding | + | 0.6264 | 62.64% |
| Thyroid receptor binding | + | 0.5444 | 54.44% |
| Glucocorticoid receptor binding | - | 0.4916 | 49.16% |
| Aromatase binding | + | 0.6093 | 60.93% |
| PPAR gamma | + | 0.7494 | 74.94% |
| Honey bee toxicity | - | 0.6941 | 69.41% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | + | 0.5100 | 51.00% |
| Fish aquatic toxicity | + | 0.7489 | 74.89% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.93% | 98.95% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 99.24% | 93.10% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 99.23% | 90.08% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 98.21% | 97.64% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 98.01% | 93.99% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.90% | 96.09% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 95.73% | 95.56% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 95.15% | 97.14% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 94.95% | 88.56% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 94.92% | 92.97% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 93.98% | 98.24% |
| CHEMBL3837 | P07711 | Cathepsin L | 93.71% | 96.61% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 93.38% | 95.89% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.06% | 91.11% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 93.00% | 91.71% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 91.67% | 83.82% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 89.42% | 94.45% |
| CHEMBL217 | P14416 | Dopamine D2 receptor | 89.16% | 95.62% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 89.09% | 89.00% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 88.44% | 95.83% |
| CHEMBL5896 | O75164 | Lysine-specific demethylase 4A | 87.83% | 99.09% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 87.68% | 95.38% |
| CHEMBL2095226 | P05556 | Integrin alpha-5/beta-1 | 87.11% | 96.39% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 87.10% | 97.09% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 86.90% | 94.66% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 86.35% | 93.56% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 85.35% | 99.23% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 85.26% | 100.00% |
| CHEMBL2563 | Q9UQL6 | Histone deacetylase 5 | 84.95% | 89.67% |
| CHEMBL2535 | P11166 | Glucose transporter | 84.35% | 98.75% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 84.06% | 80.71% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 83.88% | 82.69% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 83.18% | 93.00% |
| CHEMBL3202 | P48147 | Prolyl endopeptidase | 82.75% | 90.65% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 82.56% | 95.89% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 82.31% | 96.67% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 82.26% | 97.23% |
| CHEMBL236 | P41143 | Delta opioid receptor | 81.76% | 99.35% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 81.47% | 85.14% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 81.29% | 99.17% |
| CHEMBL6175 | Q9H3R0 | Lysine-specific demethylase 4C | 81.29% | 96.69% |
| CHEMBL4051 | P13569 | Cystic fibrosis transmembrane conductance regulator | 80.95% | 95.71% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 80.94% | 95.93% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 80.57% | 97.25% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 80.15% | 100.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Lycium chinense |
| PubChem | 14430290 |
| LOTUS | LTS0240503 |
| wikiData | Q104402518 |